Correction: ARISE-a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design.

Fulcher, Gregory R; Jarlov, Henrik; Piltoft, Johanne Spanggaard; Singh, Kiran Pal; Liu, Lei; Mohamed, Mafauzy; Nicodemus, Nemencio Almare; Al-Jaser, Saleh Jaser; Kok, Adri

Fulcher, Gregory R; Jarlov, Henrik; Piltoft, Johanne Spanggaard; Singh, Kiran Pal; Liu, Lei; Mohamed, Mafauzy; Nicodemus, Nemencio Almare; Al-Jaser, Saleh Jaser; Kok, Adri.

Afiliación

Fulcher GR; Department of Diabetes, Endocrinology and Metabolism, Royal North Shore Hospital, Sydney, NSW, Australia. greg.fulcher@sydney.edu.au.
Jarlov H; Northern Clinical School, University of Sydney, Sydney, NSW, Australia. greg.fulcher@sydney.edu.au.
Piltoft JS; Novo Nordisk Pharma Gulf LLC, Dubai, UAE.
Singh KP; Novo Nordisk A/S, Søborg, Denmark.
Liu L; Department of Endocrinology, Fortis Hospital, Mohali, Punjab, India.
Mohamed M; Novo Nordisk A/S, Søborg, Denmark.
Nicodemus NA; Department of Medicine, Hospital Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Al-Jaser SJ; Department of Biochemistry and Molecular Biology, University of the Philippines-College of Medicine, Manila, Philippines.
Kok A; Department of Internal Medicine, Specialised Medical Center, Riyadh, Saudi Arabia.

Endocrine ; 75(3): 964, 2022 Mar.

Article en En | MEDLINE | ID: mdl-34919203

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Endocrine Asunto de la revista: ENDOCRINOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google